BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38101781)

  • 21. Can C-Reactive Protein-Lymphocyte Ratio Be Used as a Screening Tool to Confirm the Diagnosis of Periprosthetic Joint Infection?
    Balta O; Astan S; Altınayak H; Uçar C; Aytekin FY; Kurnaz R
    Clin Orthop Surg; 2023 Dec; 15(6):917-927. PubMed ID: 38045571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sjögren's syndrome with and without neurological involvement.
    Seeliger T; Kramer E; Konen FF; Zehrfeld N; Beider S; Prenzler NK; Gödecke V; Witte T; Skripuletz T; Ernst D
    J Neurol; 2023 Jun; 270(6):2987-2996. PubMed ID: 36802030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation of sleep disturbance and related factors in patients with primary Sjögren's syndrome].
    Wang YF; Fan Z; Cheng YB; Jin YB; Huo Y; He J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1063-1068. PubMed ID: 33331314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of enthesopathy in patients with primary Sjogren's syndrome: ultrasonographic study of a local cohort.
    Sag S; Sag MS; Tekeoglu I; Kamanlı A; Nas K
    J Med Ultrason (2001); 2018 Jan; 45(1):121-127. PubMed ID: 28646319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between IL-7 and primary Sjögren's syndrome: A single-center study and a systematic scoping review.
    Liang Y; Zhang Z; Li J; Luo W; Jiang T; Yang Z
    Int Immunopharmacol; 2022 Jul; 108():108758. PubMed ID: 35405597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and risk factors for primary Sjögren's syndrome combined with interstitial lung disease: a retrospective study.
    Yang Z; Zhao H; Shan L; Wang D
    Acta Biochim Pol; 2024; 71():12461. PubMed ID: 38721305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
    Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
    Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.
    de Frémont GM; Costedoat-Chalumeau N; Lazaro E; Belkhir R; Guettrot-Imbert G; Morel N; Nocturne G; Molto A; Goulenok T; Diot E; Perard L; Ferreira-Maldent N; Le Besnerais M; Limal N; Martis N; Abisror N; Debouverie O; Richez C; Sobanski V; Maurier F; Sauvetre G; Levesque H; Timsit MA; Tieulié N; Orquevaux P; Bienvenu B; Mahevas M; Papo T; Lartigau-Roussin C; Chauvet E; Berthoux E; Sarrot-Reynauld F; Raffray L; Couderc M; Silva NM; Jourde-Chiche N; Belhomme N; Thomas T; Poindron V; Queyrel-Moranne V; Delforge J; Le Ray C; Pannier E; Mariette X; Le Guern V; Seror R;
    Lancet Rheumatol; 2023 Jun; 5(6):e330-e340. PubMed ID: 38251600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of emerging inflammatory markers for predicting oxygen support requirement in COVID-19 patients.
    Kamjai P; Hemvimol S; Bordeerat NK; Srimanote P; Angkasekwinai P
    PLoS One; 2022; 17(11):e0278145. PubMed ID: 36441688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
    Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
    Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological differences between primary Sjögren's syndrome and Sjögren's syndrome accompanied by scleroderma.
    Kucuk U; Sarioglu S; Cetin P; Sari I; Birlik M
    Indian J Pathol Microbiol; 2018; 61(3):319-322. PubMed ID: 30004047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a nomogram for predicting fatigue in patients with primary Sjögren's syndrome.
    Zhao R; Dong C; Gu Z; Ding X; Li J
    Clin Rheumatol; 2024 Feb; 43(2):717-724. PubMed ID: 38153615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of diagnosis and disease course in primary Sjögren's syndrome: Results from datamining of electronic health records.
    Sandhya P; Janardana R; Sudarsanam T; Mahasampath G; Prakash JAJ; Danda D
    Int J Rheum Dis; 2019 Sep; 22(9):1768-1774. PubMed ID: 31328441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors.
    Quartuccio L; Gandolfo S; Zabotti A; Zandonella Callegher S; Fabro C; De Vita S
    Front Immunol; 2019; 10():1527. PubMed ID: 31354708
    [No Abstract]   [Full Text] [Related]  

  • 35. Incorporation of Salivary Gland Ultrasonography Into the American College of Rheumatology/European League Against Rheumatism Criteria for Primary Sjögren's Syndrome.
    van Nimwegen JF; Mossel E; Delli K; van Ginkel MS; Stel AJ; Kroese FGM; Spijkervet FKL; Vissink A; Arends S; Bootsma H
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):583-590. PubMed ID: 31254454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study).
    Meiners PM; Vissink A; Kroese FG; Spijkervet FK; Smitt-Kamminga NS; Abdulahad WH; Bulthuis-Kuiper J; Brouwer E; Arends S; Bootsma H
    Ann Rheum Dis; 2014 Jul; 73(7):1393-6. PubMed ID: 24473674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
    Bowman SJ; Fox R; Dörner T; Mariette X; Papas A; Grader-Beck T; Fisher BA; Barcelos F; De Vita S; Schulze-Koops H; Moots RJ; Junge G; Woznicki JN; Sopala MA; Luo WL; Hueber W
    Lancet; 2022 Jan; 399(10320):161-171. PubMed ID: 34861168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren's syndrome.
    Le Goff M; Cornec D; Jousse-Joulin S; Guellec D; Costa S; Marhadour T; Le Berre R; Genestet S; Cochener B; Boisrame-Gastrin S; Renaudineau Y; Pers JO; Saraux A; Devauchelle-Pensec V
    Arthritis Res Ther; 2017 Dec; 19(1):269. PubMed ID: 29208023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prevalence of Sjögren's Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features.
    Kim H; Cho SK; Kim HW; Han J; Kim Y; Hwang KG; Sung YK
    J Korean Med Sci; 2020 Nov; 35(45):e369. PubMed ID: 33230982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
    Seror R; Bootsma H; Saraux A; Bowman SJ; Theander E; Brun JG; Baron G; Le Guern V; Devauchelle-Pensec V; Ramos-Casals M; Valim V; Dörner T; Tzioufas A; Gottenberg JE; Solans Laqué R; Mandl T; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Priori R; Bartoloni E; Goeb V; Praprotnik S; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Meiners P; Brito-Zerón P; Vitali C; Mariette X;
    Ann Rheum Dis; 2016 Feb; 75(2):382-9. PubMed ID: 25480887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.